Thiopurine S-Methyltransferase deficiency - TPMT genotyping - TPMT*2/ TPMT*3A/3B/3C - Pharmacogenetics

Genetic test Export to PDF
Full name:
Thiopurine S-Methyltransferase deficiency - TPMT genotyping - TPMT*2/ TPMT*3A/3B/3C - Pharmacogenetics
Description:

TPMT*2 (c.238G>C (rs1800462)), TPMT*3A (c.460G>A (rs1800460) + c.719A>G (rs1142345)), TPMT*3B (G460A), TPMT*3C (A719G).

Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA
Method category:
Method technique:
Laboratory:
RIZIV code:
EQA:
  • 2018 Thiopurine S methyltransferase ( Molecular genetics 03-Set 06 – CYP2C9 CYP2C19 VKORC1 TPMT) INSTAND e.V. (Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e. V.)
  • 2019 Thiopurine S methyltransferase ( Molecular genetics 03-Set 06 – CYP2C9 CYP2C19 VKORC1 TPMT) INSTAND e.V. (Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e. V.)
  • 2020 Thiopurine S methyltransferase ( Molecular genetics 03-Set 06 – CYP2C9 CYP2C19 VKORC1 TPMT) INSTAND e.V. (Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e. V.)
  • 2021 Thiopurine S methyltransferase ( Molecular genetics 03-Set 06 – CYP2C9 CYP2C19 VKORC1 TPMT) INSTAND e.V. (Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laboratorien e. V.)
  • 2022 pharmacogenetic panel EMQN
  • 2023 Prediction of Thiopurine toxicity (TPMT and NUDT15) GenQA (Genomics Quality Assessment)
Accreditation (ISO 15189):
2022-02-24 / 2026-02-23
Turnaround time (maximum):
2 weeks
Document(s):
Created:
23 Jul 2019 - 07:58
Changed:
16 Jan 2024 - 15:02
URL: